Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
1979; Lippincott Williams & Wilkins; Volume: 1; Issue: 3 Linguagem: Inglês
10.1161/01.hyp.1.3.274
ISSN1524-4563
AutoresSteven A. Atlas, David B. Case, Jean E. Sealey, John H. Laragh, Doris N. McKinstry,
Tópico(s)Renin-Angiotensin System Studies
ResumoHomeHypertensionVol. 1, No. 3Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBInterruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. S A Atlas, D B Case, J E Sealey, J H Laragh and D N McKinstry S A AtlasS A Atlas Search for more papers by this author , D B CaseD B Case Search for more papers by this author , J E SealeyJ E Sealey Search for more papers by this author , J H LaraghJ H Laragh Search for more papers by this author and D N McKinstryD N McKinstry Search for more papers by this author Originally published1 May 1979https://doi.org/10.1161/01.HYP.1.3.274Hypertension. 1979;1:274–280 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByGuo Z, Poglitsch M, Cowley D, Domenig O, McWhinney B, Ungerer J, Wolley M and Stowasser M (2020) Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism, Hypertension, 76:2, (488-496), Online publication date: 1-Aug-2020. Braschi A (2019) Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise, American Journal of Cardiovascular Drugs, 10.1007/s40256-018-00316-2, 19:2, (133-171), Online publication date: 1-Apr-2019. Maranta F, Spoladore R and Fragasso G (2016) Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial Hypertension Hypertension: from basic research to clinical practice, 10.1007/5584_2016_169, (37-59), . Margalef M, Bravo F, Arola-Arnal A and Muguerza B (2017) Natural Angiotensin Converting Enzyme (ACE) Inhibitors with Antihypertensive Properties Natural Products Targeting Clinically Relevant Enzymes, 10.1002/9783527805921.ch3, (45-67) Mueller C, Crossley D and Burggren W (2014) The actions of the renin–angiotensin system on cardiovascular and osmoregulatory function in embryonic chickens (Gallus gallus domesticus), Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 10.1016/j.cbpa.2014.08.004, 178, (37-45), Online publication date: 1-Dec-2014. Weir M, Hanes D and Klassen D (2012) Antihypertensive Drugs Brenner and Rector's The Kidney, 10.1016/B978-1-4160-6193-9.10049-1, (1824-1878), . Fragasso G, Maranta F, Montanaro C, Salerno A, Torlasco C and Margonato A (2012) Pathophysiologic therapeutic targets in hypertension: a cardiological point of view, Expert Opinion on Therapeutic Targets, 10.1517/14728222.2012.655724, 16:2, (179-193), Online publication date: 1-Feb-2012. Pucci M (2011) Mechanisms of drug-induced hyperkalemia, Adverse Drug Reaction Bulletin, 10.1097/FAD.0b013e32834eca66, &NA;:271, (1043-1046), Online publication date: 1-Dec-2011. Lakshmi K and Sharma S Potential of Allylmercaptocaptopril as an Anti Cataract Agent against Galactosemic Cataract in Rats: An in Vitro and in Vivo Studies, Electronic Journal of General Medicine, 10.29333/ejgm/82712, 8:2, (122-129) Zarowitz B and Lefkovitz A (2008) Recognition and Treatment of Hyperkalemia, Geriatric Nursing, 10.1016/j.gerinurse.2008.08.002, 29:5, (333-339), Online publication date: 1-Sep-2008. Saha S, Molnar J and Arora R (2016) Tissue ACE Inhibitors for Secondary Prevention of Cardiovascular Disease in Patients With Preserved Left Ventricular Function: A Pooled Meta-analysis of Randomized Placebo-controlled Trials, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248407304791, 12:3, (192-204), Online publication date: 1-Sep-2007. Hanes D and Weir M (2005) Renal Protection in Chronic Kidney Disease Hypertension, 10.1016/B978-0-7216-0258-5.50115-0, (281-294), . Ramadan F, Masoodi N and El-Solh A (2005) Clinical factors associated with hyperkalemia in patients with congestive heart failure1, Journal of Clinical Pharmacy and Therapeutics, 10.1111/j.1365-2710.2005.00638.x, 30:3, (233-239), Online publication date: 1-Jun-2005. Hedrich O, Patten R and De Nofrio D (2005) Current treatment options for CHF management: Focus on the renin-angiotensin-aldosterone system, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-005-0001-7, 7:1, (3-13), Online publication date: 1-Jan-2005. Michel M, Bohner H, K??ster J, Sch??fers R and Heemann U (2004) Safety of Telmisartan in Patients with Arterial Hypertension, Drug Safety, 10.2165/00002018-200427050-00005, 27:5, (335-344), . Brewster U and Perazella M (2005) Can dual blockade of the renin–angiotensin system reduce progression of kidney disease beyond monotherapy?, Expert Opinion on Drug Safety, 10.1517/14740338.3.1.9, 3:1, (9-23), Online publication date: 1-Jan-2004. Leckie B (2001) The action of salt and captopril on blood pressure in mice with genetic hypertension, Journal of Hypertension, 10.1097/00004872-200109000-00013, 19:9, (1607-1613), Online publication date: 1-Sep-2001. Menard J and Patchett A (2001) Angiotensin-converting enzyme inhibitors Drug Discovery and Design, 10.1016/S0065-3233(01)56002-7, (13-75), . Rustom R, Grime J, Sells R, Amara A, Jackson M, Shenkin A, Maltby P, Smith L, Hammad A, Brown M and Bone J (2009) RENAL TUBULAR PEPTIDE CATABOLISM IN CHRONIC VASCULAR REJECTION, Renal Failure, 10.1081/JDI-100104734, 23:3-4, (517-531), Online publication date: 1-Jan-2001. Perazella M (2000) Drug-induced hyperkalemia: old culprits and new offenders, The American Journal of Medicine, 10.1016/S0002-9343(00)00496-4, 109:4, (307-314), Online publication date: 1-Sep-2000. Keilani T, Danesh F, Schlueter W, Molteni A and Batlle D (1999) A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium, American Journal of Kidney Diseases, 10.1016/S0272-6386(99)70181-2, 33:3, (450-457), Online publication date: 1-Mar-1999. Brown N and Vaughan D (1998) Angiotensin-Converting Enzyme Inhibitors, Circulation, 97:14, (1411-1420), Online publication date: 14-Apr-1998. Perazella M and Mahnensmith R (1997) Hyperkalemia in the elderly, Journal of General Internal Medicine, 10.1046/j.1525-1497.1997.07128.x, 12:10, (646-656), Online publication date: 1-Oct-1997. Gennari F (1998) Disorders of Potassium Metabolism Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS, 10.1007/978-1-4757-6632-5_4, (53-83), . Keilani T, Schlueter W and Batlle D (2013) Selected Aspects of ACE Inhibitor Therapy for Patients with Renal Disease: Impact on Proteinuria, Lipids and Potassium, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1995.tb04750.x, 35:1, (87-97), Online publication date: 1-Jan-1995. Berecek K and Zhang L (1995) Biochemistry and Cell Biology of Angiotensin-Converting Enzyme and Converting Enzyme Inhibitors Tissue Renin-Angiotensin Systems, 10.1007/978-1-4899-0952-7_9, (141-168), . Ruilope L, Lahera V, Rodicio J and Carlos Romero J (1994) Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?, Hypertension, 23:1, (3-9), Online publication date: 1-Jan-1994. Lowenthal D (1994) Clinical Pharmacology - Physiology Conference, Geriatric Nephrology and Urology, 10.1007/BF01436052, 4:2, (121-125), Online publication date: 1-Jun-1994. Bhuyan K, Bhuyan D, Santos O and Podos S (1992) Antioxidant and anticataractogenic effects of topical captopril in diquat-induced cataract in rabbits, Free Radical Biology and Medicine, 10.1016/0891-5849(92)90112-T, 12:4, (251-261), Online publication date: 1-Jan-1992. Weber M, Neutel J and Smith D (1992) Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition, American Heart Journal, 10.1016/0002-8703(92)91063-7, 123:5, (1414-1420), Online publication date: 1-May-1992. Kolloch R (1992) ACE-Hemmer-Therapie und Natrium-Volumen-Regulation Bedeutung von Natrium und Chlorid für den Menschen, 10.1007/978-3-642-77340-2_12, (143-159), . Curry S and Arnold-Capell P (1991) Nitroprusside, Nitroglycerin, and Angiotensin-Converting Enzyme Inhibitors, Critical Care Clinics, 10.1016/S0749-0704(18)30296-3, 7:3, (555-581), Online publication date: 1-Jul-1991. Bauer J and Reams G (1991) Die Niere als Causa und Zielorgan der Hochdruckkrankheit Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie, 10.1007/978-3-642-76361-8_14, (145-161), . Ruffolo R, Hieble J, Brooks D, Feuerstein G and Nichols A (1991) Drug receptors and control of the cardiovascular system: Recent advances Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, 10.1007/978-3-0348-7136-5_4, (117-360), . Webb R, Miller D, Traina V and Gomez H (1990) Benazepril, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1990.tb00432.x, 8:2, (89-104), Online publication date: 1-Jun-1990. Bauer H, Lametschwandtner A, Steiner M and Bauer H (1990) Influence of angiotensin converting enzyme inhibitor (captopril) on kidney epithelial cells in vitro: studies on potassium (86Rb) influx and cellular proliferation, Clinica Chimica Acta, 10.1016/0009-8981(90)90260-Y, 187:1, (47-53), Online publication date: 1-Jan-1990. Reams G and Bauer J (1990) Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney, Cardiovascular Drugs and Therapy, 10.1007/BF01857635, 4:1, (207-219), Online publication date: 1-Jan-1990. Mason N (2016) Angiotensin-Converting Enzyme Inhibitors and Renal Function, DICP, 10.1177/106002809002400511, 24:5, (496-505), Online publication date: 1-May-1990. Fischli W, Hefti F and Clozel J (2012) Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1989.tb03476.x, 27:S2, (151S-158S), Online publication date: 1-Apr-1989. Johnston G and Passmore A (2012) The effects of cilazapril alone and in combination with frusemide in healthy subjects., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1989.tb03487.x, 27:S2, (235S-242S), Online publication date: 1-Apr-1989. Oliver R, Peacock A, Fleming J and Waller D (1989) Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease., Thorax, 10.1136/thx.44.6.513, 44:6, (513-515), Online publication date: 1-Jun-1989. RUFFOLO R and NICHOLS A (1988) Recent Experimental and Conceptual Advances in Drug Receptor Research in the Cardiovascular System , 10.1016/B978-0-12-013317-8.50007-1, (235-348), . Jin M, Wilhelm M, Lang R, Unger T, Lindpaintner K and Ganten D (1988) Endogenous tissue renin-angiotensin systems, The American Journal of Medicine, 10.1016/0002-9343(88)90202-1, 84:3, (28-36), Online publication date: 1-Mar-1988. Quintanilla A and Weffer M (2018) Hyperkalemia in the Patient on Chronic Dialysis, The International Journal of Artificial Organs, 10.1177/039139888701000105, 10:1, (17-19), Online publication date: 1-Jan-1987. Becker R and Schölkens B (1987) Ramipril: Review of pharmacology, The American Journal of Cardiology, 10.1016/0002-9149(87)90045-2, 59:10, (D3-D11), Online publication date: 1-Apr-1987. Becker R, Baldes L and Treudler M (2009) Synergism Of Ce-Inhibition and Diuresis. A study with ramipril, Piretanide and HCT in SHR, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968709164196, 9:2-3, (357-360), Online publication date: 1-Jan-1987. Errichetti A and Johnson B (1987) Antihypertensive drugs Drugs for Heart Disease, 10.1007/978-1-4899-3294-5_8, (237-274), . Daskalopoulos G, Pinzani M, Murray N, Hirschberg R and Zipser R (1987) Effects of captopril on renal function in patients with cirrhosis and ascites, Journal of Hepatology, 10.1016/S0168-8278(87)80542-1, 4:3, (330-336), Online publication date: 1-Jan-1987. Andreucci V, Conte G, Canton A, Minno G and Usberti M (2009) The Causal Role of Salt Depletion in Acute Renal Failure Due to Captopril in Hypertensive Patients with a Single Functioning Kidney and Renal Artery Stenosis, Renal Failure, 10.3109/08860228709047640, 10:1, (9-20), Online publication date: 1-Jan-1987. Borek M, Charlap S and Frishman W (2012) Enalapril: A Long-acting Angiotensin-Converting Enzyme Inhibitor, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1987.tb04039.x, 7:5, (133-145), Online publication date: 10-Sep-1987. Brunner H, Waeber B and Nussberger J (2009) Pharmacology of Converting Enzyme Inhibitors, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968709164187, 9:2-3, (275-288), Online publication date: 1-Jan-1987. DiBianco R (2012) Adverse Reactions with Angiotensin Converting Enzyme (ACE) Inhibitors, Medical Toxicology, 10.1007/BF03259832, 1:2, (122-141), Online publication date: 1-Apr-1986. Bauer J and Reams G (1986) Renal effects of angiotensin converting enzyme inhibitors in hypertension, The American Journal of Medicine, 10.1016/0002-9343(86)90940-X, 81:4, (19-27), Online publication date: 1-Oct-1986. Melby J (1986) The renin-angiotensin-aldosterone complex, The American Journal of Medicine, 10.1016/0002-9343(86)90938-1, 81:4, (8-12), Online publication date: 1-Oct-1986. Säynäväulammi P (2009) Effects of Captopril on the Urinary Excretion of Prostanoids and Kallikrein in Spontaneously Hypertensive Rats, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1986.tb00170.x, 59:4, (285-290) Ando K, Fujita T, Ito Y, Noda H and Yamashita K (1986) The role of renal hemodynamics in the antihypertensive effect of captopril, American Heart Journal, 10.1016/0002-8703(86)90152-3, 111:2, (347-352), Online publication date: 1-Feb-1986. Eggena P, Barrett J, Sambhi M and Fredal A (1986) Renin substrate and the renin-angiotensin system in hog tissues, Biochemical Medicine and Metabolic Biology, 10.1016/0885-4505(86)90110-6, 36:1, (82-90), Online publication date: 1-Aug-1986. Bussmann W (1986) Converting Enzyme Inhibition: Therapy for Chronic Heart Failure Acute and Chronic Heart Failure, 10.1007/978-3-642-61627-3_21, (252-279), . Semplicini A, Rossi G, Bongiovì S, Perissinotto F, Samà B, Mozzato M and Pessina A (1986) TIME COURSE OF CHANGES IN BLOOD PRESSURE, ALDOSTERONE AND BODY FLUIDS DURING ENALAPRIL TREATMENT: A DOUBLE-BLIND RANDOMIZED STUDY VS HYDROCHLOROTHIAZIDE PLUS PROPRANOLOL IN ESSENTIAL HYPERTENSION, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1986.tb00311.x, 13:1, (17-24), Online publication date: 1-Jan-1986. Brater D (1986) Serum electrolyte abnormalities caused by drugs Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, 10.1007/978-3-0348-9311-4_1, (9-69), . Bauer J and Gaddy P (1985) Effects of Enalapril Alone, and in Combination With Hydrochlorothiazide, on Renin-Angiotensin-Aldosterone, Renal Function, Salt and Water Excretion, and Body Fluid Composition, American Journal of Kidney Diseases, 10.1016/S0272-6386(85)80177-3, 6:4, (222-232), Online publication date: 1-Oct-1985. DiBianco R (2016) Angiotensin converting enzyme inhibition, Postgraduate Medicine, 10.1080/00325481.1985.11699167, 78:5, (229-248), Online publication date: 1-Oct-1985. Sokolow M and Mcllroy M (1985) Hypertonie Kardiologie, 10.1007/978-3-642-69607-7_9, (247-345), . ANDRÉN L, KARLBERG B, SVENSSON A, ÖHMAN P, NILSSON O and HANSSON L (2009) Long-term Effects of Captopril and Atenolol in Essential Hypertension, Acta Medica Scandinavica, 10.1111/j.0954-6820.1985.tb01651.x, 217:2, (155-160) Alhenc-Gelas F, Corvol P and Menard J (1984) New pharmacological approaches in the treatment of mild hypertension. The potential role of converting enzyme inhibitors and calcium blocking agents Mild hypertension, 10.1007/978-3-642-87506-9_13, (118-126), . Martin M, Mckenna F, Bird H, Surrall K, Dixon J and Wright V (1984) CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?, The Lancet, 10.1016/S0140-6736(84)91821-X, 323:8390, (1325-1328), Online publication date: 1-Jun-1984. Atlas S, Case D, Yu Z and Laragh J (1984) Hormonal and Metabolic Effects of Angiotensin Converting Enzyme Inhibitors, The American Journal of Medicine, 10.1016/S0002-9343(84)80053-4, 77:2, (13-17), Online publication date: 1-Aug-1984. Bauer J (1984) Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension, The American Journal of Medicine, 10.1016/S0002-9343(84)80057-1, 77:2, (43-51), Online publication date: 1-Aug-1984. Pinto A, Riolo F, Notarbartolo A, Avellone G, Galati D, Clemenza F, Gullotti D and Strano A (1984) Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs Thrombosis and Cardiovascular Disease, 10.1007/978-1-4684-8616-2_29, (283-297), . Alhenc-Gelas F, Corvol P and Menard J (1984) New pharmacological approaches in the treatment of mild hypertension. The potential role of converting enzyme inhibitors and calcium blocking agents Mild Hypertension, 10.1007/978-3-642-85334-0_13, (118-126), . Miller D, Watkins B, Hopkins M, Tonnesen S and Van Orsdell D (1984) Antihypertensive assessment of two new angiotensin-converting enzyme (ACE) inhibitors: CGS 13945 and CGS 13934, Drug Development Research, 10.1002/ddr.430040206, 4:2, (179-189), . Tschöpe W and Weber E (1984) Klinische Pharmakologie der antihypertensiven Pharmakotherapie Arterielle Hypertonie, 10.1007/978-3-662-00760-0_35, (661-686), . DUCHIN K and WILLARD D (2013) The Effect of Captopril on Renal Hemodynamics in Hypertensive Patients, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1984.tb02787.x, 24:8-9, (351-359), Online publication date: 9-Aug-1984. Bauer J and Jones L (1984) Comparative Studies: Enalapril Versus Hydrochlorothiazide as First-Step Therapy for the Treatment of Primary Hypertension, American Journal of Kidney Diseases, 10.1016/S0272-6386(84)80027-X, 4:1, (55-62), Online publication date: 1-Jul-1984. Mason J and Hilton P (1983) Reversible renal failure due to captopril in a patient with transplant artery stenosis. Case report., Hypertension, 5:4, (623-627), Online publication date: 1-Jul-1983. Griffing G, Sindler B, Aurechia S and Melby J (1983) Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): A new angiotensin-converting enzyme inhibitor, Metabolism, 10.1016/0026-0495(83)90129-4, 32:7, (711-716), Online publication date: 1-Jul-1983. Frohlich E (1983) Achievements in hypertension: A 25 year overview, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80024-2, 1:1, (225-239), Online publication date: 1-Jan-1983. Vetter W and Vetter H (1983) Antihypertensiva bei therapieresistenter Hypertonie Therapie mit Antihypertensiva, 10.1007/978-3-642-69048-8_3, (141-148), . Mimran A (2009) Renal Aspects of Treatment by Converting Enzyme Inhibitors in Hypertension, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968309048864, 5:7-8, (1381-1394), Online publication date: 1-Jan-1983. DiNicolantonio R (1983) FAILURE OF CAPTOPRIL TO LOWER BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS OFFERED WATER AND SALINE TO DRINK, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1983.tb00195.x, 10:3, (269-272), Online publication date: 1-Jun-1983. Fallo F, Maragno I, Merola P and Mantero F (2009) Effect of Captopril on Blood Pressure and on the Renin-Angiotensin-Aldosterone System in Coarctation of the Aorta, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968309069491, 5:3, (321-328), Online publication date: 1-Jan-1983. Mullane K, Moncada S and Vane J (1983) Does Prostaglandin Release Contribute to the Hypotension Induced by Inhibitors of Angiotensin Converting Enzyme? Prostaglandins and the Kidney, 10.1007/978-1-4684-4277-9_21, (213-233), . van Zwieten P, de Jonge A and Timmermans P (1983) Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs, Pharmaceutisch Weekblad, 10.1007/BF02332943, 5:5, (197-204), Online publication date: 1-Oct-1983. Bourgoignie J (1983) Salt, diuretics and resistance to treatment Lifelong Management of Hypertension, 10.1007/978-94-009-6732-8_5, (57-72), . Wenting G, Man in't veld A, Woittiez A, Boomsma F, Laird-Meeter K, Simoons M, Hugenholtz P and Schalekamp M (1983) Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone., Heart, 10.1136/hrt.49.1.65, 49:1, (65-76), Online publication date: 1-Jan-1983. Atkinson A, Cumming A, Brown J, Fraser R, Leckie B, Lever A, Morton J and Robertson J (2012) Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1982.tb01878.x, 13:6, (855-858), Online publication date: 1-Jun-1982. Case D, Atlas S, Marion R and Laragh J (1982) Long-term efficacy of captopril in renovascular and essential hypertension, The American Journal of Cardiology, 10.1016/0002-9149(82)90358-7, 49:6, (1440-1446), Online publication date: 1-Apr-1982. Aurell M, Delin K and Herlitz H (2010) Captopril in Treatment-Resistant Essential and Renal Hypertension, Scandinavian Journal of Urology and Nephrology, 10.3109/00365598209179761, 16:3, (243-249), Online publication date: 1-Jan-1982. Gavras H, Biollaz J, Waeber B, Gavras I, Brunner H and Davies R (2009) Effects of the New Oral Angiotensin Converting Enzyme Inhibitor MK-421 In Human Hypertension, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968209061593, 4:1-2, (303-314), Online publication date: 1-Jan-1982. Andren L, Karlberg B, Ohman P, Svensson A, Asplund J and Hansson L (2012) Captopril and atenolol combined with hydrochlorothiazide in essential hypertension., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1982.tb02066.x, 14:S2, (107S-111S), Online publication date: 1-Apr-1982. Waeber B, Gavras I, Brunner H, Cook C, Charocopos F and Gavras H (1982) Prediction of sustained antihypertensive efficacy of chronic captopril therapy: Relationships to immediate blood pressure response and control plasma renin activity, American Heart Journal, 10.1016/0002-8703(82)90278-2, 103:3, (384-390), Online publication date: 1-Mar-1982. Staessen J, Fagard R, Lijnen P and Amery A (1982) Inhibitors of the Renin-Angiotensin System as Antihypertensive Agents Hypertensive Cardiovascular Disease: Pathophysiology and Treatment, 10.1007/978-94-009-7476-0_53, (837-872), . Steingo L, Pocock W, Flax H, Stein M and Barlow J (2012) Long-term captopril therapy in severe refractory congestive heart failure., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1982.tb02078.x, 14:S2, (203S-208S), Online publication date: 1-Apr-1982. Whitman H, Case D, Laragh J, Christian C, Botstein G, Maricq H and Leroy E (1982) Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients, Arthritis & Rheumatism, 10.1002/art.1780250301, 25:3, (241-248), Online publication date: 1-Mar-1982. Atkinson A, Brown J, Cumming A, Fraser R, Lever A, Leckie B, Morton J and Robertson J (1982) Captopril in renovascular hypertension: long-term use in predicting surgical outcome., BMJ, 10.1136/bmj.284.6317.689, 284:6317, (689-693), Online publication date: 6-Mar-1982. Lijnen P, Staessen J, Fagard R and Amery A (1982) Increase in plasma aldosterone during prolonged captopril treatment, The American Journal of Cardiology, 10.1016/0002-9149(82)90390-3, 49:6, (1561-1563), Online publication date: 1-Apr-1982. Havelka J, Vetter H, Studer A, Greminger P, Lüscher T, Wollnik S, Siegenthaler W and Vetter W (1982) Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension, The American Journal of Cardiology, 10.1016/0002-9149(82)90362-9, 49:6, (1467-1474), Online publication date: 1-Apr-1982. Rosenthal T, Holtzman E and Yaron A (2009) Angiotensin-I Converting Enzyme Activity in the Sera of Captopril-Treated Hypertensive Patients, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968209060749, 4:3, (367-377), Online publication date: 1-Jan-1982. Aldigier J, Plouin P, Guyene T, Thibonnier M, Corvol P and Menard J (1982) Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension, The American Journal of Cardiology, 10.1016/0002-9149(82)90359-9, 49:6, (1447-1452), Online publication date: 1-Apr-1982. Weber M, Drayer J, Purdy R and Laragh J (2009) The Role of Aldosterone in the Response to Treatment of Primary Hypertension, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968209061650, 4:9-10, (1923-1934), Online publication date: 1-Jan-1982. Textor S, Bravo E, Fouad F and Tarazi R (1982) Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril, The American Journal of Medicine, 10.1016/0002-9343(82)90415-6, 73:5, (719-725), Online publication date: 1-Nov-1982. Ward P and Sheridan M (1982) Angiotensin I converting enzyme of rat intestinal and vascular surface membrane, Biochimica et Biophysica Acta (BBA) - General Subjects, 10.1016/0304-4165(82)90270-7, 716:2, (208-216), Online publication date: 1-May-1982. Ferguson R, Vlasses P, Swanson B, Mojaverian P and Koplin J (1982) Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension, Life Sciences, 10.1016/0024-3205(82)90636-1, 30:1, (59-65), Online publication date: 1-Jan-1982. Atkinson A, Brown J, Cumming A, Fraser R, Lever A, Leckie B, Morton J, Robertson J and Davies D (1982) Captopril in the management of hypertension with renal artery stenosis: Its long-term effect as a predictor of surgical outcome, The American Journal of Cardiology, 10.1016/0002-9149(82)90361-7, 49:6, (1460-1466), Online publication date: 1-Apr-1982. Case D, Atlas S, Sullivan P and Laragh J (1981) Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril., Circulation, 64:4, (765-771), Online publication date: 1-Oct-1981.Trippodo N and Frohlich E (1981) Similarities of genetic (spontaneous) hypertension. Man and rat., Circulation Research, 48:3, (309-319), Online publication date: 1-Mar-1981. Hulthén U, Dymling J, Bramnert M and Hökfelt B (1981) The Effect of Captopril on Urinary Kinins and Urinary Kallikrein Activity in Essential Hypertension Frontiers in Hypertension Research, 10.1007/978-1-4612-5899-5_88, (532-537), . Ferguson R and Vlasses P (1981) Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril, American Heart Journal, 10.1016/0002-8703(81)90233-7, 101:5, (650-656), Online publication date: 1-May-1981. Unger T, Rockhold R, Bönner G, Rascher W, Schaz K, Speck G, Schömig A and Ganten D (2009) Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive Rats, Clinical and Experimental Hypertension, 10.3109/10641968109037172, 3:1, (121-140), Online publication date: 1-Jan-1981. Gavras H, Waeber B, Gavras I, Biollaz J, Brunner H and Davies R (1981) ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"., The Lancet, 10.1016/S0140-6736(81)90937-5, 318:8246, (543-547), Online publication date: 1-Sep-1981. Forslund T, Tikkanen I, Grönhagen-Riska C and Fyhrquist F (2009) Dissociation of the Effect of Captopril on Blood Pressure and Angiotensin Converting Enzyme in Serum and Lungs of Spontaneously Hypertensive Rats, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1981.tb00925.x, 49:5, (416-421) THIBONNIER M, SOTO M, MENARD J, ALDIGER J, CORVOL P and MILLIEZ P (1981) Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril, European Journal of Clinical Investigation, 10.1111/j.1365-2362.1981.tb02012.x, 11:6, (449-453), Online publication date: 1-Dec-1981. Weber M, Purdy R and Hurlbut D (1981) Aldosterone: Possible Roles in Sustaining Essential Hypertension and in Determining Response to Antihypertensive Treatment Frontiers in Hypertension Research, 10.1007/978-1-4612-5899-5_78, (462-469), . Maitra S, Scicli A, Miyazaki S and Carretero O (1981) Role of mineralocorticoid in the chronic antihypertensive effect of converting enzyme inhibitor., Hypertension, 3:2, (205-210), Online publication date: 1-Mar-1981. Hollenberg N, Meggs L, Williams G, Katz J, Garnic J and Harrington D (1981) Sodium intake and renal responses to captopril in normal man and in essential hypertension, Kidney International, 10.1038/ki.1981.126, 20:2, (240-245), Online publication date: 1-Aug-1981. Hamilton D, Evans D, Maidment G and Pryor J (2018) Captopril for Refractory Hypertension in Patients with Chronic Renal Failure and Renal Transplantation, Journal of the Royal Society of Medicine, 10.1177/014107688107400507, 74:5, (357-362), Online publication date: 1-May-1981. ANGELI A, BISBOCCI D, ORLANDI F, PACCOTTI P, TABASSO R, TAMAGNONE C and LAVEZZARO G (1981) PITUITARY—ADRENOCORTICAL FUNCTION IN PATIENTS DURING TREATMENT WITH THE ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CAPTOPRIL, Clinical Endocrinology, 10.1111/j.1365-2265.1981.tb00701.x, 15:6, (555-565), Online publication date: 1-Dec-1981. Atlas S and Case D (1981) 8 Renin in essential hypertension, Clinics in Endocrinology and Metabolism, 10.1016/S0300-595X(81)80012-6, 10:3, (537-575), Online publication date: 1-Nov-1981. Jackson E, Cardoni A, Harris C and Smith G (2016) Captopril (Capoten®, E.R. Squibb & Sons), Drug Intelligence & Clinical Pharmacy, 10.1177/106002808101501203, 15:12, (932-939), Online publication date: 1-Dec-1981. Pierpont G, Francis G and Cohn J (1981) Effect of captopril on renal function in patients with congestive heart failure., Heart, 10.1136/hrt.46.5.522, 46:5, (522-527), Online publication date: 1-Nov-1981. Atlas S, Case D, Sullivan P, Sealey J and Laragh J (1981) Immediate and Delayed Antihypertensive Effects of Angiotensin-Converting Enzyme Inhibition with Captopril Frontiers in Hypertension Research, 10.1007/978-1-4612-5899-5_84, (517-521), . LEDINGHAM J (2012) IMPLICATIONS OF ANTIHYPERTENSIVE THERAPY ON SODIUM BALANCE AND SODIUM AND WATER RETENTION, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1981.tb00290.x, 12, (15S-21S), Online publication date: 1-May-1981. Studer A, L�scher T, Siegenthaler W and Vetter W (1981) Captopril in various forms of severe therapy-resistant hypertensionCaptopril bei therapieresistenter Hypertonie, Klinische Wochenschrift, 10.1007/BF01477284, 59:2, (59-67), Online publication date: 1-Jan-1981. GIESE J and RASMUSSEN S (1981) Converting enzyme inhibition: a novel concept in drug therapy of hypertension, European Journal of Clinical Investigation, 10.1111/j.1365-2362.1981.tb01992.x, 11:5, (341-343), Online publication date: 1-Oct-1981. Mimran A, Targhetta R and Laroche B (1980) The antihypertensive effect of captopril. Evidence for an influence of kinins., Hypertension, 2:6, (732-737), Online publication date: 1-Nov-1980. Campbell S and Danilewicz J (1980) Chapter 9. Antihypertensive Agents , 10.1016/S0065-7743(08)60370-X, (79-88), . Ward P, Sheridan M, Hammon K and Erdös E (1980) Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine, Biochemical Pharmacology, 10.1016/0006-2952(80)90603-6, 29:11, (1525-1529), Online publication date: 1-Jun-1980. Hoorntje S, Donker A, Prins E and Weening J (2009) Membranous Glomerulopathy in a Patient on Captopril, Acta Medica Scandinavica, 10.1111/j.0954-6820.1980.tb01203.x, 208:1-6, (325-329) Ferguson R, Vlasses P, Koplin J, Shirinian A, Burke J and Alexander J (1980) Captopril in severe treatment-resistant hypertension, American Heart Journal, 10.1016/0002-8703(80)90730-9, 99:5, (579-585), Online publication date: 1-May-1980. Tarazi R, Bravo E, Fouad F, Omvik P and Cody R (1980) Hemodynamic and volume changes associated with captopril., Hypertension, 2:4, (576-585), Online publication date: 1-Jul-1980. Atkinson A, Morton J, Brown J, Davies D, Fraser R, Kelly P, Leckie B, Lever A and Robertson J (1980) Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition., Heart, 10.1136/hrt.44.3.290, 44:3, (290-296), Online publication date: 1-Sep-1980. Antonaccio M, Rubin B and Horovitz Z (2009) Effects of Captopril in Animal Models of Hypertension, Clinical and Experimental Hypertension, 10.3109/10641968009037133, 2:3-4, (613-637), Online publication date: 1-Jan-1980. Weber M and Drayer J (1980) Renal effects of beta-adrenoceptor blockade, Kidney International, 10.1038/ki.1980.186, 18:5, (686-699), Online publication date: 1-Nov-1980. Rosendahl W and Hayduk K (1980) Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril, European Journal of Pediatrics, 10.1007/BF00441635, 135:2, (161-164), Online publication date: 1-Dec-1980. Rubin B, Antonaccio M and Horovitz Z (1980) Captopril (Capoten®; SQ 14,225) (d-3-Mercapto-2-methylpropanoyl-l-proline) Captopril and Hypertension, 10.1007/978-1-4615-9179-5_9, (115-135), . Rubin B, Antonaccio M and Horovitz Z (1980) The Renin-Angiotensin System, Converting Enzyme Inhibition, and Antihypertensive Therapy Progress in Hormone Biochemistry and Pharmacology, 10.1007/978-94-011-7712-2_1, (1-53), . (1980) Inhibitors of angiotensin I converting enzyme for treating hypertension., BMJ, 10.1136/bmj.281.6241.630, 281:6241, (630-631), Online publication date: 6-Sep-1980. Brunner R, Gavras H and Waeber B (2009) Enhancement by Diuretics of the Antihypertensive Action of Long-Term Angiotensin Converting Enzyme Blockade, Clinical and Experimental Hypertension, 10.3109/10641968009037134, 2:3-4, (639-657), Online publication date: 1-Jan-1980. Ferguson R, Vlasses P and Swanson B (1980) Effects of captopril, diuretic, and their combination in low-renin essential hypertension, Life Sciences, 10.1016/0024-3205(80)90532-9, 27:25-26, (2519-2522), Online publication date: 1-Dec-1980. Witzgall H (1980) Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysisHeilung einer malignen Hypertonie durch Behandlung mit Captopril bei einem Dialysepatienten, Klinische Wochenschrift, 10.1007/BF01476998, 58:17, (871-873), Online publication date: 1-Sep-1980. Atkinson A and Robertson J (1979) CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE, The Lancet, 10.1016/S0140-6736(79)92186-X, 314:8147, (836-839), Online publication date: 1-Oct-1979. Resnick L, Catanzaro D, Sealey J and Laragh J (2011) Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system, Cardiovascular Therapy and Prevention, 10.15829/1728-8800-2011-6-35-41, 10:6, (35-41) May 1979Vol 1, Issue 3 Advertisement Article InformationMetrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.HYP.1.3.274PMID: 399239 Originally publishedMay 1, 1979 PDF download Advertisement
Referência(s)